Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lifestyle, Mushroom Supplementation, and Bupropion for Overweight and Cardiometabolic Risk
NCT07806279Phase 3Not yet recruiting
- Sponsor
- Uppsala University
- Start
- Oct 2026
- Primary completion
- Dec 2030
- Countries
- 1
01
Overview
A Phase 3 trial of bupropion in obesity, metabolic syndrome, sponsored by Uppsala University. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
bupropion
03
Conditions
obesitymetabolic syndrome
Beyond the preview
Go deeper on NCT07806279.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07806279.